CD163 and osteosarcoma: A high number of CD14+/HLA-DRα+ macrophages was also associated with a better OS, vascularity and a better response to chemotherapy treatment in osteosarcoma; however, the M2 phenotype of CD14+/CD163+ macrophages was not related to OS [58].